Latest News and Press Releases
Want to stay updated on the latest news?
-
Copenhagen, 2014-05-15 13:00 CEST (GLOBE NEWSWIRE) -- ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today announced that its ragweed sublingual allergy immunotherapy tablet, which is licensed...
-
København, 2014-05-15 13:00 CEST (GLOBE NEWSWIRE) -- ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) meddeler i dag, at den sublinguale tabletbaserede vaccine mod ragweedallergi, som ALK har...
-
Copenhagen, 2014-05-12 15:26 CEST (GLOBE NEWSWIRE) -- ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF): Pursuant to section 28(a) of the Danish Securities Trading Act, ALK-Abelló A/S shall report...
-
København, 2014-05-12 15:26 CEST (GLOBE NEWSWIRE) -- ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF): I henhold til værdipapirhandelslovens § 28a følger hermed indberetning af transaktioner...
-
København, 2014-05-08 08:00 CEST (GLOBE NEWSWIRE) -- Bemærk venligst, at kvartalsrapporten kun foreligger på engelsk. Performance for the period (unaudited) (Comparative figures for...
-
Copenhagen, 2014-05-08 08:00 CEST (GLOBE NEWSWIRE) -- Performance for the period (unaudited) (Comparative figures for 2013 are shown in brackets / revenue growth is measured in local...
-
Copenhagen, 2014-05-01 16:00 CEST (GLOBE NEWSWIRE) -- ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) will host an R&D and business briefing for the investment community on Wednesday, 21 May...
-
Copenhagen, 2014-04-29 10:31 CEST (GLOBE NEWSWIRE) -- R&D and Business Briefing in NYC on 21 May ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today announced that the Company will...
-
København, 2014-04-28 09:00 CEST (GLOBE NEWSWIRE) -- ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF): Flemming Steen Jensen (53), koncerndirektør for produktion og medlem af direktionen i ALK,...
-
Copenhagen, 2014-04-28 09:00 CEST (GLOBE NEWSWIRE) -- ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF): After 14 years with ALK, Flemming Steen Jensen (53), Executive Vice President Product...